Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.395 USD | +2.57% | +6.87% | +19.66% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.66% | 102M | |
+11.72% | 116B | |
+12.19% | 106B | |
-9.07% | 23.89B | |
-2.82% | 21.58B | |
-11.02% | 18.96B | |
-40.50% | 16.96B | |
-13.88% | 16.33B | |
+6.67% | 14.14B | |
+31.03% | 12.02B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Transcript : Clearside Biomedical, Inc., Q4 2021 Earnings Call, Mar 10, 2022